Please login to the form below

Not currently logged in
Email:
Password:

SOBI

This page shows the latest SOBI news and features for those working in and with pharma, biotech and healthcare.

Sobi’s Gamifant receives final rejection from CHMP for primary HLH

Sobi’s Gamifant receives final rejection from CHMP for primary HLH

Sobi requested that the CHMP re-examine the application for Gamifant (emapalumab) as a treatment for of primary haemophagocytic lymphohistiocytosis (HLH) after the Committee initially rejected the drug in July. ... In the US, over 100 primary HLH

Latest news

More from news
Approximately 12 fully matching, plus 14 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

  • New hires at FibroGen, Saniona and Turbine New hires at FibroGen, Saniona and Turbine

    Most recently, Levin worked as the president of Sobi, where he was responsible for building the organisation and developing the strategic growth pillars of the company. ... Prior to Sobi, Levin held commercial leadership roles of increasing strategic

  • BMS appoints new commercial leader, Davies joins Eisai and more BMS appoints new commercial leader, Davies joins Eisai and more

    Sobi appoints head of technical operations. Rare disease specialist company Sobi has appointed Anne Marie de Jonge Schuermans to front its new technical operations organisation. ... operations. She joins Sobi from Biogen, where she served as vice

  • Sobi poaches Pfizer’s Fredrick Wetterlundh Sobi poaches Pfizer’s Fredrick Wetterlundh

    Swedish Orphan Biovitrum (Sobi) has appointed Fredrik Wetterlundh as head of human resources and will simultaneously be part of Sobi’s extended leadership team. ... Guido Oelkers, CEO and president of Sobi, said: “His experience from the

  • Mereo BioPharma appoints head of patient access and commercial planning Mereo BioPharma appoints head of patient access and commercial planning

    Wills Hughes-Wilson joins the group from Sobi. London, UK-based Mereo BioPharma, has strengthened its team with the addition of Wills Hughes-Wilson, who joins the biopharma as its new ... In this role, Hughes-Wilson was responsible for Sobi’s

  • Sobi names Holly May VP of sales and marketing, US Sobi names Holly May VP of sales and marketing, US

    Rare disease firm Sobi has appointed Holly May as its new vice president of sales and marketing for the US. ... May’s new role will see her lead the biopharma’s commercial team in bringing Sobi’s medicines to the country.

More from appointments
Approximately 9 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • The RARE Youth Revolution has begun The RARE Youth Revolution has begun

    LifeArc. Sobi. “We are a proud supporter of RARE Youth Revolution and we are absolutely thrilled to have them as part of the Breaking Down Barriers project!

  • IGNIFI IGNIFI

    Kyowa Kirin. Sobi. Theramex. Veriton Pharma. Vifor Pharma.

  • Say Communications Say Communications

    Novo Nordisk. Nutricia. Nutricia Global. SOBI. Target Ovarian Cancer. Trudell Medical.

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Spirit, an OPEN Health Company

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...